At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

The Mount Sinai oncologist studies innate immune cells with the goal of designing novel immunotherapies, including cancer vaccines.

Researchers describe ways to study how cancer cells evade therapies that harness the immune system.

A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.

The technology has wowed the field by all but obliterating some patients’ blood cancers, but solid malignancies present new challenges.

Tumor accessibility, heterogeneity, and microenvironment vary between the two classes of malignancies.

The manuscript had amassed more than 50 comments about problematic figures and data on PubPeer.

Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.

The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.